Hudbay Minerals Inc. Ordinary Shares (Canada) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.14 (market cap $11.52B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5× Hudbay Minerals Inc. Ordinary Shares (Canada)'s market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold Hudbay Minerals Inc. Ordinary Shares (Canada) for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| HBM | TAK | |
|---|---|---|
Market Cap | $11.52B | $58.16B |
Volume | 4,227,671 | 2,467,530 |
Sector | Basic Materials | Health |
52-Week High | $31.87 | $19.05 |
52-Week Low | $14.58 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.58B | $86.04B |
Dividend Yield | 0.11% | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →